BIVI Company Profile and Key Details

Q: Who are the executives of BIVI?

Mr. Cuong Viet Do M.B.A., MBAPres, Chief Executive Officer & DirectorDr. Joseph M. Palumbo M.D.Chief Medical OfficerMs. Joanne Wendy Kim CPAChief Financial Officer, Treasurer & Corporation Sec.Dr. Penelope Markham Ph.D.Executive Vice President of Liver Disease R&DMs. Denise SmithSenior Vice President of Manufacturing & Devel.Mr. Clarence N. AhlemExecutive Vice President of Neuroscience Product Devel.Ms. Sarah Overton HoitChief Social Impact Officer

NASDAQ : BIVI

BioVie

$1.58

0.02+1.28%

Open: 1:56 PM

63.39

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

BioVie Inc. (BIVI) stock surged +1.28%, trading at $1.58 on NASDAQ, up from the previous close of $1.56. The stock opened at $1.68, fluctuating between $1.48 and $1.70 in the recent session.

Stock Snapshot

1.56

Prev. Close

11.92M

Market Cap

1.48

Day Low

-0.59

P/E Ratio

-2.68617

EPS (TTM)

-1.08

Cash Flow per Share

1.68

Open

7.54M

Number of Shares

1.7

Day High

86.94%

Free Float in %

0.2

Book Value

4.15M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 12, 2026	1.35	3.79	1.31	1.56	124.24M
Aug 11, 2026	1.09	1.42	1.09	1.27	2.69M
Aug 10, 2026	0.99	1.16	0.99	1.10	1.25M
Aug 07, 2026	1.22	1.23	0.98	1.00	3.32M
Aug 06, 2026	1.36	1.41	0.82	1.35	8.75M
Aug 05, 2026	1.89	2.09	1.87	2.04	246.92K
Aug 04, 2026	1.63	1.90	1.54	1.83	395.45K
Aug 03, 2026	1.50	1.65	1.46	1.62	119.44K
Jul 31, 2026	1.45	1.55	1.38	1.52	203.38K
Jul 30, 2026	1.30	1.45	1.30	1.43	225.45K
Jul 29, 2026	1.34	1.40	1.26	1.26	81.59K
Jul 28, 2026	1.36	1.40	1.31	1.33	106.21K
Jul 27, 2026	1.36	1.43	1.35	1.37	75.56K
Jul 24, 2026	1.45	1.49	1.34	1.37	112.04K
Jul 23, 2026	1.34	1.46	1.34	1.44	85.37K
Jul 22, 2026	1.28	1.38	1.28	1.34	105.45K
Jul 21, 2026	1.41	1.46	1.26	1.29	306.01K
Jul 20, 2026	1.41	1.49	1.32	1.43	684.11K
Jul 17, 2026	1.66	1.81	1.66	1.80	105.8K
Jul 16, 2026	1.73	1.80	1.68	1.72	72.9K

Contact Details

Carson City, NV 89703

United States

https://bioviepharma.com 775 888 3162

About Company

BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potential applications in treating multiple myeloma and prostate cancer. Established in 2013, the company adopted its current name, BioVie Inc., in July 2016, having previously operated as NanoAntibiotics, Inc. Its corporate headquarters are situated in Carson City, Nevada.

Stock Peers

ARGX

11.26+1.30%

argenx SE$876.00 REGN

0.99+0.12%

Regeneron Pharmaceuticals, Inc.$797.99 MDGL

0.93+0.17%

Madrigal Pharmaceuticals, Inc.$536.20 VRTX

-3.92-0.74%

Vertex Pharmaceuticals Incorporated$525.73 UTHR

-3.78-0.73%

United Therapeutics Corporation$511.72 PRAX

15.65+4.22%

Praxis Precision Medicines, Inc.$386.33 ONC

-0.22-0.06%

BeOne Medicines AG$359.05 KRYS

5.81+1.78%

Krystal Biotech, Inc.$332.86 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

4.52+1.57%

Ligand Pharmaceuticals Incorporated$293.27

Frequently Asked Questions

What is the current BioVie Inc. (BIVI) stock price?

BioVie Inc. (NASDAQ: BIVI) stock price is $1.58 in the last trading session. During the trading session, BIVI stock reached the peak price of $1.70 while $1.48 was the lowest point it dropped to. The percentage change in BIVI stock occurred in the recent session was 1.28% while the dollar amount for the price change in BIVI stock was $0.02.

BIVI's industry and sector of operation?

The NASDAQ listed BIVI is part of Biotechnology industry that operates in the broader Healthcare sector. BioVie Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BIVI?

Mr. Cuong Viet Do M.B.A., MBA
Pres, Chief Executive Officer & Director
Dr. Joseph M. Palumbo M.D.
Chief Medical Officer
Ms. Joanne Wendy Kim CPA
Chief Financial Officer, Treasurer & Corporation Sec.
Dr. Penelope Markham Ph.D.
Executive Vice President of Liver Disease R&D
Ms. Denise Smith
Senior Vice President of Manufacturing & Devel.
Mr. Clarence N. Ahlem
Executive Vice President of Neuroscience Product Devel.
Ms. Sarah Overton Hoit
Chief Social Impact Officer

How BIVI did perform over past 52-week?

BIVI's closing price is 90.24% higher than its 52-week low of $0.82 where as its distance from 52-week high of $3.79 is -58.84%.

How many employees does BIVI have?

Number of BIVI employees currently stands at 13.

Link for BIVI official website?

Official Website of BIVI is: https://bioviepharma.com

How do I contact BIVI?

BIVI could be contacted at phone 775 888 3162 and can also be accessed through its website. BIVI operates from 680 West Nye Lane, Carson City, NV 89703, United States.

How many shares of BIVI are traded daily?

BIVI stock volume for the day was 4.15M shares. The average number of BIVI shares traded daily for last 3 months was 2.4M.

What is the market cap of BIVI currently?

The market value of BIVI currently stands at $11.92M with its latest stock price at $1.58 and 7.54M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	13
Beta	0.67
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

Employees	13
Beta	0.67
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

BIVI Company Profile and Key Details

BioVie

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook